Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 20 of 99

  1. BLCL-ETN-ANV-01

    Laboratorios Tillomed Spain S.L.U

    No medical condition

    phase 1 other active

    1 trial

  2. BLCL-ETN-ANV-02

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  3. BLCL-LEN-EU-01

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  4. BLCL-LEN-FDA-01

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  5. BLCL-LEN-FDA-02

    Lacuna Pharma Pty Ltd

    No medical condition

    phase 1 other active

    1 trial

  6. BLCL-LEN-FDA-03

    Lacuna Pharma Pty Ltd

    No medical condition

    phase 1 other active

    1 trial

  7. BLCL-LIS-CAN-01

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  8. BLCL-LIS-EU-01

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  9. BLCL-LIS-EU-02

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  10. BLCL-LIS-EU-03

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  11. BLCL-LIS-PIL01

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  12. BLCL-NIL-FDA-02

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  13. BLCL-RUX-EU-01

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  14. BLCL-RUX-FDA-01

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  15. BLCL-RUX-PIL01

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  16. BLCL-TOF-EU-01

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  17. BLCL-TOF-FDA-03

    Lacuna Pharma Pty Ltd

    No medical condition

    phase 1 other active

    1 trial

  18. BLCL-TOF-FDA-04

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  19. BMB-101

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  20. BMN 111 administration via Injector Pen

    BioMarin Pharmaceutical Australia Pty Ltd

    Achondroplasia

    phase 1 other terminated

    1 trial

  21. BMN 255

    BioMarin Pharmaceutical Australia Pty Ltd

    Hyperoxaluria

    phase 1 small molecule terminated

    1 trial

  22. BMN 349

    BioMarin Pharmaceutical Australia Pty Ltd

    Alpha 1-Antitrypsin Deficiency

    phase 1 small molecule active

    1 trial

  23. BMP-655/ACS+Standard of care or Standard of care

    Pfizer

    Rotator Cuff Tear

    phase 1 mab terminated

    1 trial

  24. BMS-641988 (AR#2)

    Bristol-Myers Squibb

    Prostate Cancer

    phase 1 small molecule completed

    1 trial

  25. BMS-906024

    Bristol-Myers Squibb

    Cancer

    phase 1 small molecule completed

    1 trial

  26. BMS-986148

    Bristol-Myers Squibb

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  27. BMS-986202

    Bristol-Myers Squibb

    Psoriasis

    phase 1 small molecule completed

    1 trial

  28. BMS-986500

    Bristol-Myers Squibb

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  29. BN44083

    Hoffmann-La Roche

    Multiple Sclerosis (MS)

    phase 1 other active

    1 trial

  30. BNT116-01

    BioNTech SE

    Advanced non-small cell lung cancer

    phase 1 other active

    1 trial

  31. BNT164-01

    BioNTech SE

    Tuberculosis

    phase 1 other active

    1 trial

  32. BNT211-01

    BioNTech SE

    Solid Tumors

    phase 1 small molecule active

    1 trial

  33. BNT314

    BioNTech SE

    Advanced or metastatic malignant solid tumors

    phase 1 small molecule active

    1 trial

  34. BNT351-01

    BioNTech SE

    HIV-1 infection

    phase 1 other active

    1 trial

  35. BO42203

    Hoffmann-La Roche

    Diffuse large B-cell lymphoma (DLBCL), Grade 3B follicular lymphoma, High grade B-cell lymphoma (HGBL), Epstein-Barr virus−positive DLBCL

    phase 1 other active

    1 trial

  36. BO45287

    Hoffmann-La Roche

    Relapsed or Refractory Chronic Lymphocytic Leukemia (R/R CLL)

    phase 1 other active

    1 trial

  37. BOSUT-09-24

    Lacuna Pharma Pty Ltd

    myeloid leukemia

    phase 1 other active

    1 trial

  38. BP1.4979 / P24-01

    Bioprojet Pharma

    Binge eating disorder

    phase 1 other active

    1 trial

  39. BP41628

    Hoffmann-La Roche

    Solid Tumors

    phase 1 other active

    1 trial

  40. BP42230

    Hoffmann-La Roche

    Multiple Sclerosis (MS)

    phase 1 other active

    1 trial

  41. BP42233

    Hoffmann-La Roche

    Relapsed or Refractory Multiple Myeloma

    phase 1 other active

    1 trial

  42. BP43015

    Hoffmann-La Roche

    Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

    phase 1 other active

    1 trial

  43. BP43131

    Hoffmann-La Roche

    Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma (r/r NHL)

    phase 1 other active

    1 trial

  44. BP44382

    Hoffmann-La Roche

    Small Cell Lung Cancer and Neuroendocrine Carcinoma

    phase 1 other active

    1 trial

  45. BP44551

    Hoffmann-La Roche

    Moderate to Severe Asthma

    phase 1 other active

    1 trial

  46. BP44956

    Hoffmann-La Roche

    Advanced and/or Metastatic Solid Tumors

    phase 1 other active

    1 trial

  47. BP45211

    Hoffmann-La Roche

    Alzheimer’s Disease (AD)

    phase 1 other active

    1 trial

  48. BP45228

    Hoffmann-La Roche

    Not applicable, healthy volunteers

    phase 1 other active

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.